Business Description
Medivir AB
NAICS : 325412
ISIN : SE0020181014
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.35 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.03 | |||||
Beneish M-Score | -3.16 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -31.1 | |||||
3-Year EBITDA Growth Rate | -10.8 | |||||
3-Year EPS without NRI Growth Rate | -7.3 | |||||
3-Year FCF Growth Rate | 16.1 | |||||
3-Year Book Growth Rate | -19.1 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.64 | |||||
9-Day RSI | 38.19 | |||||
14-Day RSI | 41.54 | |||||
6-1 Month Momentum % | 5.97 | |||||
12-1 Month Momentum % | -50.45 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.48 | |||||
Quick Ratio | 2.48 | |||||
Cash Ratio | 2.38 | |||||
Days Sales Outstanding | 304.43 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -42.5 | |||||
Shareholder Yield % | -5.76 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1622.07 | |||||
Net Margin % | -1549.93 | |||||
FCF Margin % | -1271.07 | |||||
ROE % | -60.33 | |||||
ROA % | -45.29 | |||||
ROIC % | -72.72 | |||||
ROC (Joel Greenblatt) % | -862.25 | |||||
ROCE % | -57 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 41.91 | |||||
PB Ratio | 1.82 | |||||
Price-to-Tangible-Book | 4.01 | |||||
EV-to-EBIT | -1.54 | |||||
EV-to-Forward-EBIT | -1.48 | |||||
EV-to-EBITDA | -1.58 | |||||
EV-to-Forward-EBITDA | -1.48 | |||||
EV-to-Revenue | 23.95 | |||||
EV-to-Forward-Revenue | 28.47 | |||||
EV-to-FCF | -1.88 | |||||
Price-to-Median-PS-Value | 1.73 | |||||
Price-to-Net-Current-Asset-Value | 4.67 | |||||
Price-to-Net-Cash | 5 | |||||
Earnings Yield (Greenblatt) % | -64.94 | |||||
FCF Yield % | -27.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medivir AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 6.834 | ||
EPS (TTM) (kr) | -1.366 | ||
Beta | 0.68 | ||
Volatility % | 50.28 | ||
14-Day RSI | 41.54 | ||
14-Day ATR (kr) | 0.196054 | ||
20-Day SMA (kr) | 3.082 | ||
12-1 Month Momentum % | -50.45 | ||
52-Week Range (kr) | 2.33 - 6.759036 | ||
Shares Outstanding (Mil) | 112.17 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medivir AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medivir AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Medivir AB Frequently Asked Questions
What is Medivir AB(OSTO:MVIR)'s stock price today?
When is next earnings date of Medivir AB(OSTO:MVIR)?
Does Medivir AB(OSTO:MVIR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |